These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 1974934)

  • 1. Mechanisms and modulation of multidrug resistance in primary human renal cell carcinoma.
    Mickisch GH; Roehrich K; Koessig J; Forster S; Tschada RK; Alken PM
    J Urol; 1990 Sep; 144(3):755-9. PubMed ID: 1974934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circumvention of multidrug resistance mediated by P-170 glycoprotein using calcium antagonists in primary human renal cell carcinoma.
    Mickisch GH; Kössig J; Tschada RK; Keilhauer G; Schlick E; Alken PM
    Urol Int; 1991; 47(3):118-25. PubMed ID: 1685271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-glycoprotein and alterations in the glutathione/glutathione-peroxidase cycle underlie doxorubicin resistance in HL-60-R, a subclone of the HL-60 human leukemia cell line.
    Raghu G; Pierre-Jerome M; Dordal MS; Simonian P; Bauer KD; Winter JN
    Int J Cancer; 1993 Mar; 53(5):804-11. PubMed ID: 8095491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines.
    Lai GM; Moscow JA; Alvarez MG; Fojo AT; Bates SE
    Int J Cancer; 1991 Nov; 49(5):688-95. PubMed ID: 1682279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of calcium antagonists in multidrug resistant primary human renal cell carcinomas.
    Mickisch GH; Kössig J; Keilhauer G; Schlick E; Tschada RK; Alken PM
    Cancer Res; 1990 Jun; 50(12):3670-4. PubMed ID: 2340516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New potent verapamil derivatives that reverse multidrug resistance in human renal carcinoma cells and in transgenic mice expressing the human MDR1 gene.
    Mickisch GH; Merlino GT; Aiken PM; Gottesman MM; Pastan I
    J Urol; 1991 Aug; 146(2):447-53. PubMed ID: 1677434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifactorial resistance in LS174T human colon carcinoma cells selected with doxorubicin.
    Rabier MJ; Bruno NA; Slate DL
    Int J Cancer; 1991 Oct; 49(4):601-7. PubMed ID: 1680816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined in vitro modulation of adriamycin resistance.
    Meijer C; Mulder NH; Timmer-Bosscha H; Peters WH; de Vries EG
    Int J Cancer; 1991 Oct; 49(4):582-6. PubMed ID: 1680815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of P-glycoprotein and multidrug resistance in renal cell carcinoma.
    Naito S; Sakamoto N; Kotoh S; Goto K; Matsumoto T; Kumazawa J
    Eur Urol; 1993; 24(1):156-60. PubMed ID: 8103456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of buthionine sulfoximine on toxicity of verapamil and doxorubicin to multidrug resistant cells and to mice.
    Ford JM; Yang JM; Hait WN
    Cancer Res; 1991 Jan; 51(1):67-72. PubMed ID: 1988108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of calcium antagonists in the treatment of chemoresistant cancer of the kidney].
    Mickisch G; Kössig J; Tschada R; Keilhauer G; Schlick E; Alken P
    J Urol (Paris); 1990; 96(3):121-7. PubMed ID: 1976711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of glutathione and its related enzymes on chemosensitivity of renal cell carcinoma and bladder carcinoma cell lines.
    Ahn H; Lee E; Kim K; Lee C
    J Urol; 1994 Jan; 151(1):263-7. PubMed ID: 8254825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-170 glycoprotein, glutathione and associated enzymes in relation to chemoresistance of primary human renal cell carcinomas.
    Mickisch G; Bier H; Bergler W; Bak M; Tschada R; Alken P
    Urol Int; 1990; 45(3):170-6. PubMed ID: 1971972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Enhancement of cytotoxic effect of anticancer agents of renal cell carcinoma].
    Okano M; Kawamoto S; Nezasa S; Tamaki M; Ehara H; Yamada S; Deguchi T; Kawada Y
    Nihon Hinyokika Gakkai Zasshi; 1996 Aug; 87(8):1041-7. PubMed ID: 8831211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of antitumour drug resistance: experimental laboratory data and results of clinical evaluation.
    Hill BT
    Cancer Treat Rev; 1990 Sep; 17(2-3):197-202. PubMed ID: 1980233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of various chemosensitizers on chemoresistance to adriamycin in MIP-101 cell line, a colon carcinoma cell line: analysis of glutathione and related enzymes.
    Mestdagh N; Morier-Teissier E; Hénichart JP
    Anticancer Drugs; 1993 Dec; 4(6):641-50. PubMed ID: 7905301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of multiple drug resistance in human bladder cancer cell lines.
    Shinohara N; Liebert M; Wedemeyer G; Chang JH; Grossman HB
    J Urol; 1993 Aug; 150(2 Pt 1):505-9. PubMed ID: 8100862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein.
    Zaman GJ; Lankelma J; van Tellingen O; Beijnen J; Dekker H; Paulusma C; Oude Elferink RP; Baas F; Borst P
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7690-4. PubMed ID: 7644478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming tumor necrosis factor-alpha resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and tumor necrosis factor-alpha. Role of tumor necrosis factor-alpha mRNA down-regulation in tumor cell sensitization.
    Mizutani Y; Yoshida O
    Cancer; 1994 Feb; 73(3):730-7. PubMed ID: 8299097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verapamil enhances doxorubicin activity in cultured human renal carcinoma cells.
    Lai T; Collins CM; Hall P; Morgan AP; Smith PJ; Stonebridge BR; Symes MO
    Eur J Cancer; 1993; 29A(3):378-83. PubMed ID: 8104443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.